Calix Inc has a consensus price target of $56.5 based on the ratings of 12 analysts. The high is $88 issued by Loop Capital on January 27, 2023. The low is $30 issued by Jefferies on April 25, 2024. The 3 most-recent analyst ratings were released by Roth MKM, Needham, and JP Morgan on July 23, 2024, July 23, 2024, and July 22, 2024, respectively. With an average price target of $43.33 between Roth MKM, Needham, and JP Morgan, there's an implied 23.67% upside for Calix Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/23/2024 | Buy Now | 25.57% | Roth MKM | Scott Searle | $43 → $44 | Maintains | Buy | Get Alert |
07/23/2024 | Buy Now | 28.42% | Needham | Ryan Koontz | $45 → $45 | Reiterates | Buy → Buy | Get Alert |
07/22/2024 | Buy Now | 17.01% | JP Morgan | Samik Chatterjee | $28 → $41 | Maintains | Neutral | Get Alert |
05/20/2024 | Buy Now | 28.42% | Needham | Ryan Koontz | → $45 | Reiterates | Buy → Buy | Get Alert |
04/25/2024 | Buy Now | -14.38% | Jefferies | George Notter | $48 → $30 | Downgrade | Buy → Hold | Get Alert |
04/24/2024 | Buy Now | 17.01% | Craig-Hallum | Christian Schwab | $48 → $41 | Maintains | Buy | Get Alert |
04/24/2024 | Buy Now | 22.72% | Roth MKM | Scott Searle | $50 → $43 | Maintains | Buy | Get Alert |
04/24/2024 | Buy Now | 28.42% | Needham | Ryan Koontz | $50 → $45 | Maintains | Buy | Get Alert |
04/23/2024 | Buy Now | 42.69% | Needham | Ryan Koontz | → $50 | Reiterates | Buy → Buy | Get Alert |
04/23/2024 | Buy Now | -0.11% | Rosenblatt | Mike Genovese | $45 → $35 | Maintains | Buy | Get Alert |
04/22/2024 | Buy Now | 42.69% | Roth MKM | Scott Searle | → $50 | Maintains | Buy | Get Alert |
04/17/2024 | Buy Now | 42.69% | Needham | Ryan Koontz | → $50 | Reiterates | Buy → Buy | Get Alert |
01/31/2024 | Buy Now | 42.69% | Needham | Ryan Koontz | $55 → $50 | Maintains | Buy | Get Alert |
01/30/2024 | Buy Now | 28.42% | Rosenblatt | Mike Genovese | $57 → $45 | Maintains | Buy | Get Alert |
01/03/2024 | Buy Now | 62.67% | Rosenblatt | Mike Genovese | $47 → $57 | Maintains | Buy | Get Alert |
10/25/2023 | Buy Now | 19.86% | JP Morgan | Samik Chatterjee | $51 → $42 | Maintains | Neutral | Get Alert |
10/25/2023 | Buy Now | 62.67% | Roth MKM | Leo Mariani | $66 → $57 | Maintains | Buy | Get Alert |
10/25/2023 | Buy Now | 34.13% | Rosenblatt | Mike Genovese | $70 → $47 | Maintains | Buy | Get Alert |
10/24/2023 | Buy Now | 151.14% | Needham | Ryan Koontz | → $88 | Reiterates | Buy → Buy | Get Alert |
10/13/2023 | Buy Now | 99.77% | Rosenblatt | Mike Genovese | → $70 | Reiterates | Buy → Buy | Get Alert |
08/25/2023 | Buy Now | 99.77% | Rosenblatt | Mike Genovese | → $70 | Reiterates | Buy → Buy | Get Alert |
07/21/2023 | Buy Now | 99.77% | Rosenblatt | Mike Genovese | → $70 | Reiterates | Buy → Buy | Get Alert |
07/21/2023 | Buy Now | 151.14% | Needham | Ryan Koontz | → $88 | Reiterates | Buy → Buy | Get Alert |
07/20/2023 | Buy Now | 99.77% | Rosenblatt | Mike Genovese | → $70 | Reinstates | Buy → Buy | Get Alert |
07/20/2023 | Buy Now | 151.14% | Needham | Ryan Koontz | → $88 | Reiterates | Buy → Buy | Get Alert |
07/18/2023 | Buy Now | 108.33% | Roth MKM | Leo Mariani | → $73 | Reiterates | Buy → Buy | Get Alert |
07/18/2023 | Buy Now | 99.77% | Rosenblatt | Mike Genovese | → $70 | Reiterates | Buy → Buy | Get Alert |
06/09/2023 | Buy Now | 99.77% | Rosenblatt | Mike Genovese | → $70 | Reiterates | Buy → Buy | Get Alert |
05/19/2023 | Buy Now | 151.14% | Needham | Ryan Koontz | → $88 | Reiterates | Buy → Buy | Get Alert |
05/19/2023 | Buy Now | 39.84% | JP Morgan | Samik Chatterjee | → $49 | Initiates | → Neutral | Get Alert |
04/24/2023 | Buy Now | 151.14% | Needham | Ryan Koontz | → $88 | Reiterates | → Buy | Get Alert |
04/21/2023 | Buy Now | 125.46% | TD Cowen | Paul Silverstein | $78 → $79 | Maintains | Outperform | Get Alert |
04/21/2023 | Buy Now | 99.77% | Rosenblatt | Mike Genovese | $75 → $70 | Maintains | Buy | Get Alert |
04/21/2023 | Buy Now | 108.33% | Roth MKM | Leo Mariani | $74 → $73 | Maintains | Buy | Get Alert |
04/20/2023 | Buy Now | 114.04% | Rosenblatt | Mike Genovese | → $75 | Reiterates | → Buy | Get Alert |
04/20/2023 | Buy Now | 151.14% | Needham | Ryan Koontz | → $88 | Reiterates | → Buy | Get Alert |
02/06/2023 | Buy Now | 114.04% | Rosenblatt | Mike Genovese | $85 → $75 | Maintains | Buy | Get Alert |
01/27/2023 | Buy Now | 151.14% | Loop Capital | Fahad Najam | $83 → $88 | Maintains | Buy | Get Alert |
01/27/2023 | Buy Now | 128.31% | Northland Capital Markets | Tim Savageaux | $85 → $80 | Maintains | Outperform | Get Alert |
12/22/2022 | Buy Now | 151.14% | Needham | Ryan Koontz | $82 → $88 | Maintains | Buy | Get Alert |
10/26/2022 | Buy Now | 142.58% | Rosenblatt | Mike Genovese | $75 → $85 | Maintains | Buy | Get Alert |
10/26/2022 | Buy Now | 134.02% | Needham | Ryan Koontz | $70 → $82 | Maintains | Buy | Get Alert |
10/18/2022 | Buy Now | 99.77% | Needham | Ryan Koontz | $63 → $70 | Maintains | Buy | Get Alert |
10/12/2022 | Buy Now | 114.04% | Rosenblatt | Mike Genovese | $65 → $75 | Maintains | Buy | Get Alert |
07/27/2022 | Buy Now | 102.63% | Cowen & Co. | Paul Silverstein | $48 → $71 | Maintains | Outperform | Get Alert |
07/27/2022 | Buy Now | 85.5% | Rosenblatt | Mike Genovese | $60 → $65 | Maintains | Buy | Get Alert |
07/27/2022 | Buy Now | 79.79% | Needham | Ryan Koontz | $60 → $63 | Maintains | Buy | Get Alert |
07/27/2022 | Buy Now | 91.21% | Barrington Research | Christopher Howe | $63 → $67 | Maintains | Outperform | Get Alert |
06/22/2022 | Buy Now | 74.09% | Jefferies | George Notter | $69 → $61 | Maintains | Buy | Get Alert |
04/27/2022 | Buy Now | 71.23% | Needham | Ryan Koontz | $73 → $60 | Maintains | Buy | Get Alert |
04/12/2022 | Buy Now | 71.23% | Rosenblatt | Mike Genovese | → $60 | Initiates | → Buy | Get Alert |
04/07/2022 | Buy Now | 28.42% | Northland Capital Markets | Tim Savageaux | → $45 | Upgrade | Market Perform → Outperform | Get Alert |
02/23/2022 | Buy Now | 99.77% | Loop Capital | Fahad Najam | → $70 | Initiates | → Buy | Get Alert |
01/28/2022 | Buy Now | 56.96% | Craig-Hallum | Christian Schwab | → $55 | Upgrade | Hold → Buy | Get Alert |
10/27/2021 | Buy Now | 108.33% | Needham | Ryan Koontz | — | Maintains | Buy | Get Alert |
07/27/2021 | Buy Now | 56.96% | Needham | Ryan Koontz | — | Maintains | Buy | Get Alert |
07/23/2021 | Buy Now | 65.53% | Barrington Research | Christopher Howe | — | Initiates | → Outperform | Get Alert |
The latest price target for Calix (NYSE:CALX) was reported by Roth MKM on July 23, 2024. The analyst firm set a price target for $44.00 expecting CALX to rise to within 12 months (a possible 25.57% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Calix (NYSE:CALX) was provided by Roth MKM, and Calix maintained their buy rating.
The last upgrade for Calix Inc happened on April 7, 2022 when Northland Capital Markets raised their price target to $45. Northland Capital Markets previously had a market perform for Calix Inc.
The last downgrade for Calix Inc happened on April 25, 2024 when Jefferies changed their price target from $48 to $30 for Calix Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calix was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.
While ratings are subjective and will change, the latest Calix (CALX) rating was a maintained with a price target of $43.00 to $44.00. The current price Calix (CALX) is trading at is $35.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.